Post Tagged with: "CDC"

CDC Rescinds Order Requiring Negative Pre-Departure COVID-19 Test Prior To Flight To The United States

  Today, CDC is announcing that the Order requiring persons to show a negative COVID-19 test result or documentation of recovery from COVID-19 before boarding a flight to the United States, will be rescinded, effective on June 12, 2022 at 12:01AM ET. This means that starting at 12:01AM ET on[Read More…]

by June 11, 2022

CDC Data Released Ahead of National Black HIV/AIDS Awareness Day

Highlights Factors that Contribute to Continuing HIV Disparities in the U.S. From The Federal Centers For Disease Control & Prevention: Despite overall progress in reducing HIV transmission in the United States, HIV continues to affect some groups more than others due to longstanding and ingrained barriers. Black or African American (hereafter referred[Read More…]

by February 3, 2022

CDC Recommends Pfizer Booster at 5 Months, Additional Primary Dose for Certain Immunocompromised Children

  Today, CDC is updating our recommendation for when many people can receive a booster shot, shortening the interval from 6 months to 5 months for people who received the Pfizer-BioNTech COVID-19 Vaccine.  This means that people can now receive an mRNA booster shot 5 months after completing their Pfizer-BioNTech primary series.  The booster interval recommendation for[Read More…]

by January 4, 2022

CDC Updates & Shortens Recommended Isolation & Quarantine Period For General Population

    Given what we currently know about COVID-19 and the Omicron variant, CDC is shortening the recommended time for isolation from 10 days for people with COVID-19 to 5 days, if asymptomatic, followed by 5 days of wearing a mask when around others. The change is motivated by science[Read More…]

by December 27, 2021

CDC Statement on B.1.1.529 – Omicron

  From The Center For Disease Control On November 26, 2021, the World Health Organization (WHO) classified a new variant, B.1.1.529, as a Variant of Concern and has named it Omicron. No cases of this variant have been identified in the U.S. to date. CDC is following the details of this new variant, first reported to the WHO by South Africa. We are grateful to the South African government[Read More…]

by November 27, 2021

CDC Expands Eligibility for COVID-19 Booster Shots

  Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation for a booster shot of COVID-19 vaccines in certain populations. The Food and Drug Administration’s (FDA) authorization and CDC’s recommendation for use are important steps forward as we work to stay ahead of the[Read More…]

by October 22, 2021

CDC Stands Up New Disease Forecasting Center

    Aims to predict disease threats, provide early warning and real-time data on outbreaks  Today, the Centers for Disease Control and Prevention (CDC) is announcing a new center designed to advance the use of forecasting and outbreak analytics in public health decision making. Once established, the Center for Forecasting[Read More…]

by August 19, 2021

Statement from CDC Director Rochelle P. Walensky, MD, MPH – Immunocompromised Individuals

  Today, I signed CDC’s Advisory Committee on Immunization Practices’ (ACIP) recommendation that endorsed the use of an additional dose of COVID-19 vaccine for people with moderately to severely compromised immune systems after an initial two-dose vaccine series. This official CDC recommendation — which follows FDA’s decision to amend the emergency[Read More…]

by August 13, 2021

FLASH! New CDC Data: COVID-19 Vaccination Safe for Pregnant People

CDC Recommends All Pregnant People or People Thinking About Becoming Pregnant Get Vaccinated Against COVID-19 CDC has released new data on the safety of the COVID-19 vaccines in pregnant people and is recommending all people 12 years of age and older get vaccinated against COVID-19. “CDC encourages all pregnant people or people[Read More…]

by August 11, 2021

CDC Morbidity & Mortality Weekly Report Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech & Moderna): Update from the Advisory Committee on Immunization Practices

 

by August 10, 2021